Haleos Labs Limi

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE320X01016
  • NSEID: HALEOSLABS
  • BSEID: 540679
INR
1,318.00
-33 (-2.44%)
BSENSE

Feb 11

BSE+NSE Vol: 508

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationNine Monthly Results
Results Snapshot
Figures in Cr
Consolidate Nine Monthly Results
Dec'25
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
Net Sales
258.65
255.61
232.13
251.83
253.81
183.08
214.80
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
258.65
255.61
232.13
251.83
253.81
183.08
214.80
Raw Material Cost
112.99
117.17
132.89
136.59
153.21
90.08
116.55
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
-3.21
-2.48
-9.34
3.56
-16.56
5.09
19.80
Employee Cost
49.22
43.07
36.53
31.98
29.34
22.06
19.81
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
51.34
48.60
41.30
42.62
49.17
34.66
29.67
Selling and Distribution Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Expenses
8.93
11.64
11.06
10.95
12.31
9.98
7.73
Total Expenditure (Excl Depreciation)
219.27
218.00
212.44
225.70
227.47
161.87
193.56
Operating Profit (PBDIT) excl Other Income
39.38
37.61
19.69
26.13
26.34
21.21
21.24
Other Income
1.56
2.54
1.53
0.95
0.71
1.05
1.41
Operating Profit (PBDIT)
40.94
40.15
21.22
27.08
27.05
22.26
22.65
Interest
5.02
6.68
7.32
4.99
4.43
3.54
3.98
Exceptional Items
0.00
0.00
0.00
0.00
7.77
0.00
0.00
Gross Profit (PBDT)
35.92
33.47
13.90
22.09
30.39
18.72
18.67
Depreciation
11.62
11.20
11.16
7.86
7.43
5.89
5.82
Profit Before Tax
24.29
22.26
2.74
14.23
22.97
12.83
12.84
Tax
6.84
7.01
2.89
4.96
6.76
4.33
4.78
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
17.46
15.25
-0.15
9.26
16.21
8.50
8.06
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
17.46
15.25
-0.15
9.26
16.21
8.50
8.06
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
-0.52
0.66
2.97
0.15
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
16.88
17.14
3.18
9.75
16.21
8.50
8.06
Equity Capital
3.02
3.02
3.02
3.02
3.02
3.02
3.02
Face Value
10.0
10.0
10.0
10.0
10.0
10.0
10.0
Reserves
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Diluted Earnings per share
21.89
18.08
14.24
13.18
7.7
8.92
-1.12
Operating Profit Margin (Excl OI)
15.23%
14.71%
8.48%
10.38%
10.38%
11.59%
9.89%
Gross Profit Margin
13.89%
13.09%
5.99%
8.77%
11.97%
10.23%
8.69%
PAT Margin
6.75%
5.97%
-0.06%
3.68%
6.39%
4.64%
3.75%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Nine Monthly Analysis Highlights
stock-summary

Net Sales

YoY Growth in nine months ended Dec 2025 is 1.19% vs 10.12% in Dec 2024

stock-summary

Consolidate Net Profit

YoY Growth in nine months ended Dec 2025 is -1.52% vs 438.99% in Dec 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in nine months ended Dec 2025 is 4.71% vs 91.01% in Dec 2024

stock-summary

Interest

YoY Growth in nine months ended Dec 2025 is -24.85% vs -8.74% in Dec 2024

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in nine months ended Dec 2025 has improved from Dec 2024

Compare Nine Monthly Results Of Haleos Labs Limi With
Markets Mojo
Figures in Cr
Consolidate Nine Monthly Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
Net Sales
258.65
0
258.65
Other Operating Income
0.00
0.00
0.00
Total Operating income
258.65
0
258.65
Raw Material Cost
112.99
0
112.99
Purchase of Finished goods
0.00
0
0.00
(Increase) / Decrease In Stocks
-3.21
0
-3.21
Employee Cost
49.22
0
49.22
Power Cost
0.00
0
0.00
Manufacturing Expenses
51.34
0
51.34
Selling and Distribution Expenses
0.00
0
0.00
Other Expenses
8.93
0.00
8.93
Total Expenditure (Excl Depreciation)
219.27
0
219.27
Operating Profit (PBDIT) excl Other Income
39.38
0.00
39.38
Other Income
1.56
0
1.56
Operating Profit (PBDIT)
40.94
0
40.94
Interest
5.02
0
5.02
Exceptional Items
0.00
0
0.00
Gross Profit (PBDT)
35.92
0
35.92
Depreciation
11.62
0
11.62
Profit Before Tax
24.29
0
24.29
Tax
6.84
0
6.84
Provisions and contingencies
0.00
0
0.00
Profit After Tax
17.46
0
17.46
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0.00
0
0.00
Other Adjustments
0.00
0
0.00
Net Profit
17.46
0
17.46
Share in Profit of Associates
0.00
0
0.00
Minority Interest
-0.52
0
-0.52
Other related items
0.00
0.00
0.00
Consolidated Net Profit
16.88
0
16.88
Equity Capital
3.02
0
3.02
Face Value
10.00
0
0.00
Reserves
0.00
0
0.00
Gross Profit Margin
13.89%
0%
0.00
13.89%
PAT Margin
6.75%
0%
0.00
6.75%
Public Share Holdings (%)
0.00%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0%
0.00
0.00%
Nine Monthly - Net Sales
Net Sales 258.65 Cr
in Dec 2025

Figures in Cr
stock-summary

YoY Growth in nine months ended Dec 2025 is 1.19% vs 10.12% in Dec 2024

Nine Monthly - Consolidate Net Profit
Consolidate Net Profit 16.88 Cr
in Dec 2025

Figures in Cr
stock-summary

YoY Growth in nine months ended Dec 2025 is -1.52% vs 438.99% in Dec 2024

Nine Monthly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 39.38 Cr
in Dec 2025

Figures in Cr
stock-summary

YoY Growth in nine months ended Dec 2025 is 4.71% vs 91.01% in Dec 2024

Nine Monthly - Interest
Interest 5.02 Cr
in Dec 2025

Figures in Cr
stock-summary

YoY Growth in nine months ended Dec 2025 is -24.85% vs -8.74% in Dec 2024

Nine Monthly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 15.23%
in Dec 2025

Figures in %
stock-summary

YoY Growth in nine months ended Dec 2025 has improved from Dec 2024